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Summary 
Using in vitro gene amplification by the polymerase 
chain reaction (PCR) and mutation detection by the 
RNAase A mismatch cleavage method, we have exam- 
ined c-K-ras genes in human pancreatic carcinomas. 
We used frozen tumor specimens and single 5 brn sec- 
tions from formalin-fixed, paraffin-embedded tumor 
tissue surgically removed or obtained at autopsy. 
Twenty-one out of 22 carcinomas of the exocrine pan- 
creas contained c-K-ras genes with mutations at codon 
12. In seven cases tested, the mutation was present in 
both primary tumors and their corresponding metas- 
tases. No mutations were detected in normal tissue 
from the same cancer patients or in five gall bladder 
carcinomas. We conclude from these results that c-K- 
ras somatic mutational activation is a critical event in 
the oncogenesis of most, if not all, human cancers of 
the exocrine pancreas. 
Introduction 
The product of the mammalian ras gene family belongs to 
the group of proto-oncogene products involved in cell 
growth and differentiation. The membrane bound ras pro- 
teins possess guanine nucleotide binding and low intrin- 
sic hydrolytic activities and appear to be involved in the 
process of signal transduction across the cellular mem- 
brane in mammals (reviewed in Barbacid, 1987). Single 
ammo acid substitutions at several positions in the protein 
lead to the activation of the ras oncogenic potential in cul- 
tured rodent fibroblasts (reviewed in Varmus, 1984). 
The role that somatic mutational activation of ras genes 
plays in mammalian tumorigenesis has been well docu- 
mented in several carcinogen-induced animal tumor model 
systems (reviewed in Barbacid, 1987). The high incidence 
of ras oncogenes and the carcinogen-specific nature of 
the activating mutations observed in some of these sys- 
tems provide strong support for the notion that ras activa- 
tion is playing a reproducible and predictable role in the 
initiation and/or progression of chemical carcinogenesis. 
ras oncogenes activated by single nucleotide substitu- 
tions have been associated with a significant percentage 
of human tumors of diverse histological origins (for a re- 
cent review, see Bos, 1987). However, information on the 
incidence of activated ras oncogenes in human cancer is 
still very incomplete. Recent advances in methods able to 
detect single point mutations in higher eukaryotic genes 
are beginning to provide accurate information on the fre- 
quency of ras oncogene activation in several types of hu- 
man tumors. For instance, activated c-K-ras oncogenes 
have been found in approximately 40% of human colo- 
rectal tumors (Bos et al., 1987, Forrester et al., 1987a). 
However, in contrast with some carcinogen-induced ani- 
mal tumor model systems, no examples of activated ras 
oncogenes present in the majority of a well-defined class 
of spontaneous human tumor have been reported. 
Using a combination of techniques, including specific in 
vitro gene amplification by the polymerase chain reaction 
or PCR (Mullis and Faloona, 1987; Saiki et al., 1985), the 
application of PCR to 5-10 km sections of formalin-fixed, 
paraffin-embedded tissue (Shibata et al., 1988), and mu- 
tation detection by cleavage at single base mismatches by 
RNAase A in DNA:RNA and RNA:RNA heteoduplexes 
(Myers et al., 1985; Winter et al., 1985) we report here the 
presence of c-K-ras genes with mutations at codon 12 in 
21 out of 22 human carcinomas of the exocrine pancreas. 
Results 
Detection of Mutant c-K-ras Genes in Human 
Pancreatic Carcinomas by RNAase A Cleavage 
of RNA: Amplified DNA Hybrids 
As part of our screening of primary human tumors for the 
presence of mutant c-K-ras genes using the RNAase A 
mismatch cleavage method (Myers et al., 1985; Winter et 
al., 1985) we analyzed pancreatic carcinomas. Total cellu- 
lar RNA was prepared from frozen tumors and hybridized 
to an antisense RNA probe corresponding to the first cod- 
ing exon of the c-K-ras gene. The RNA hybrids were then 
digested with RNAase A, and the resistant products were 
analyzed by denaturing polyacrylamide gel electrophore- 
sis. Mutant oncogenes were detected by the presence of 
RNA subbands generated by RNAase A cleavage at the 
mismatches present in the RNA:RNA heteroduplexes (For- 
rester et al., 1987a). Four human carcinomas of the exo- 
crine pancreas that we tested contained mutant c-K-ras 
genes at codon 12 (data not shown and Table l), suggest- 
ing that the frequency of mutant c-K-ras genes could be 
very high in this type of human carcinoma. 
Fresh specimens of pancreatic carcinomas are very 
scanty because of the poor prognosis of this type of hu- 
man cancer, which often precludes surgery. Therefore, we 
adapted the RNAase A mismatch cleavage method to the 
analysis of single-point mutations in c-K-ras sequences 
present in formalin-fixed paraffin-embedded tumor speci- 
mens, which are readily available from biopsies, surgical 
resections, or autopsies. The method is based on the use 
of in vitro gene amplification by PCR (Mullis and Faloona, 
1987; Saiki et al., 1985), and on the observation that a sin- 
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Table 1. Incidence of c-K-r&s Genes Mutant at Codon 12 
in Human Pancreatic Carcinomas 
Tissueb 
Case Donora N P M CommentsC 
1 67 M NA NA (4 
2 64 F NA ;A + W CC) 
3 65M - + NP (A) CC) 
4 69 F NA + NA (‘3 CC) 
5 38M - + NA (C) 
6 54M - + + 
7 32M - + + 
8 83F - + + 
9 35M - + + 
10 58 M ND ND + 
11 51F - + NA 0 
12 59F - + NP ((2 
13 62 F - + NP 
14 54 M - + ND 
15 68 M - + NA 
16 54 M - + + CC) 
17 83F - - (4 
18 80 F - + NP 
19 68 M - + + 
20 81M - + NP 
21 60 F ND + + 
22 65 M - ND + 
a The age and sex of the cancer patients is indicated. 
b Presence (+) or absence (-) of mutant c-K-ras genes in normal (N), 
primary(P), or metastatic (M) carcinoma pancreatic tissue of the same 
patient. NA: tissue not available. ND: not determined because of in- 
adequate DNA amplification. NP: metastases not present. 
c Unless otherwise indicated, the samples were analyzed using 5 nm 
formalin-fixed paraffin-embedded tissue sections obtained from autopsy 
cases by PCR amplification of c-K-ras sequences, followed by RNAase 
A mismatch cleavage of the DNA:RNA hybrids. 
(A) Cases analyzed by RNAase A cleavage of both DNA:RNA and 
RNA:RNA hybrids. PCR was performed with DNA purified from non- 
fixed tumor specimens. 
(B) Cases analyzed by RNAase A mismatch cleavage of RNA:RNA 
duplexes using total RNA from nonfixed frozen tumors. The experimen- 
tal conditions for RNA preparation, hybridization, and RNAase A diges- 
tion were as described previously (Winter et al., 1985; Forrester et al., 
1987a). 
(C) Specimens surgically removed. 
(D) This patient survived 9 months after diagnosis while the average 
survival of ten patients with the activated c-K-ras gene was only 1.9 
months (range l-4 months). 
gle 5-10 km thick formalin-fixed paraffin section is a suit- 
able substrate for PCR (Shibata et al., 1988). A 5 pm sec- 
tion of the fixed tissue is stained with hematoxylin and 
eosin for histological identification. The adjacent 5 pm 
section of the specimen is treated to remove the paraffin 
by extraction with organic solvents, and the tissue is then 
subjected to PCR. Primers complementary to the coding 
and noncoding DNA strands flanking the first coding exon 
of the c-K-ras gene are extended by E. coli DNA polymer- 
ase I (Klenow fragment). The amplification reaction is per- 
formed by successive cycles of denaturation, annealing, 
and primer-mediated elongation (Saiki et al., 1985). The 
amplified DNA product is hybridized to a RNA probe cor- 
responding to the first coding exon-of the c-K-ras gene 
(Figure l), and the RNADNA hybrids are digested with 
RNAase A and analyzed as described above. The result 
of a typical experiment is shown in Figure 2. When DNA 
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Figure 1. Schematic Representation of PCR-Mediated Amplification 
of c-K-ras Gene Sequences 
The region flanking the c-K-ras first coding exon is indicated with the 
position of the oligomers (A and B) used for in vitro amplification. The 
numbers indicate the distances (in nucleotides) and relative positions 
of the region covered by the RNA probe as well as codon 12. The open 
bars indicate intron sequences, the stippled bar exon sequences. For 
details see Experimental Procedures. 
amplified from surgically removed normal pancreatic tis- 
sue was hybridized to the RNA probe and digested with 
RNAase A, only a major protected band of about 110 
nucleotides was observed (lane 3N, corresponding to 
case 3 of Table 1). In contrast, RNAase A treatment of the 
DNA:RNA hybrids corresponding to amplified DNA bio- 
chemically purified from the SK-CO-l tumor cell line (lane 
S), which contains a c-K-ras gene with a valine mutation 
resulting from a G to T substitution at the second position 
of codon 12 (Forrester et al., 198713) generated two codon 
12 mismatch-specific subbands of 66 and 43 nucleotides 
(see Figure 1). These subbands were also present after 
hybridization and RNAase A treatment of DNA amplified 
from 5 pm sections of three distinct pancreatic carci- 
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Figure 2. RNAase A Mismatch Cleavage Analysis of PCR-Amplified 
c-K-ras DNA Sequences from Human Carcinomas of the Exocrine 
Pancreas 
DNA sequences amplified from 5 ,um sections of formalin-fixed pan- 
creatic tissues (5 nl of the 200 al PCR reaction) were hybridized to an 
uniformly labeled RNA probe directed by pAKINgly. The hybrids were 
digested with RNAase A for 30 min and analyzed in a denaturing urea- 
polyacrylamide gel. N: sections corresponding to normal pancreatic 
tissue. T and Tm: primary and metastatic tumor tissue, respectively; 
T’ : smaller areas of the sections (see Figure 3). The numbers at the 
top indicate the cases corresponding to Table 1.3N and S correspond 
to amplified c-K-r% sequences (1 al of the final PCR reactions) using 
purified DNA (1 ng) from normal pancreas of case 3 and SK-CO-l, 
respectively. Numbers at left indicate the position and size (in nucleo- 
tides) of Haelll restriction fragments of 9X174 DNA used as molecular 
weight markers (lane M). Lane P: undigested RNA probe (100 cpm). 
The picture corresponds to a 20 hr exposure of the X-ray film. 
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Figure 3. Histology of Paraffin Sections of Pancreatic Carcinomas Stained with Hematoxylin and Eosin 
(A) Case 6T’ : The section (0.4 x 04 cm) shows a poorly differentiated primary pancreatic ductal adenocarcmoma (20x). 
(6) Case 5T’ : The section (0.5 x 0.5 cm) shows a poorly differentiated primary pancreatic ductal adenocarcinoma (400x). 
nomas (cases 5, 6, and 7). Moreover, similar RNAase A 
cleavage patterns were obtained with amplified DNA from 
two different regions of the tumor specimens, a large area 
(T) and a smaller area (T*) and from either primary (T) or 
metastatic (Tm) tumors from cases 6 and 7. However, the 
mismatch-specific bands were absent when DNA was am- 
plified from 5 pm formalin-fixed paraffin sections of nor- 
mal pancreatic tissue from these cancer patients (lanes 
N). Other fainter bands were also present above and be- 
low the 110 nucleotide protected band. However, these 
bands were present in all samples, and probably represent 
incomplete digestion products and nonspecific RNAase A 
cleavage at AT-rich regions in the DNA:RNA heterodu- 
plexes. The differences in the relative intensities of the 
bands between lanes result from differences in the extent 
of DNA amplification by PCR. 
These results indicate that these three distinct pan- 
creatic carcinomas contained c-K-ras oncogenes with mu- 
tations at codon 12, and that in the two cases analyzed, 
the mutant oncogene was present in both the primary 
tumors and in their corresponding metastases. The histol- 
ogy immediately adjacent to some of the sections used for 
the experiment of Figure 2 is shown in Figure 3. 
Mutant c-K-ras Genes Are Present in Most 
Human Pancreatic Carcinomas 
Similar analysis of nine other distinct tumors (cases 8 
through 16, see Table 1) is shown in Figure 4. In all cases, 
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DNA amplified from paraffin sections corresponding to tu- 
mor tissue either primary (lanes T) or metastatic (lanes 
Tm) yielded the diagnostic codon 12 mismatch bands al- 
though their relative intensities varied between the differ- 
ent samples. In lanes 8T and 12T, the mismatch-specific 
bands were very faint. However, the presence of these 
bands was confirmed in a different experiment (data not 
shown). 
The mismatch diagnostic bands were not present when 
DNA:RNA hybrids corresponding to amplified DNA from 
5 pm sections of normal tissue (pancreas or kidney) from 
the same cancer patients were digested with RNAase A 
(lanes N), although in some cases the nonspecific back- 
ground bands were quite prominent (for instance, the 
band located between the 66 and the 43 nucleotide sub- 
bands). A diffuse band migrating slightly faster than the 
66 nucleotide mismatch-specific subband was also pres- 
ent in some of the normal samples. However, no back- 
ground band was present at the position of the smaller 43 
nucleotide mismatch-specific subband in any of the lanes 
corresponding to amplified DNA from normal tissues. 
Therefore, this band represents the clearest diagnostic 
feature of the presence of a mutant c-K-ras gene at codon 
12 in all of these tumor samples. Five additional pan- 
creatic carcinomas (cases 18-22, Table 1) were found 
positive in the assay (data not shown). 
The bands of 66 and 43 nucleotides are not due to an 
artifact dependent on the nature of the tumor tissue in the 
formalin fixed sections because they were absent when 5 
pm paraffin sections from a carcinoma of the exocrine 
pancreas (case 17, Table 1) and from five gall bladder car- 
cinomas were similarly analyzed (data not shown). 
The results of these experiments are summarized in Ta- 
ble 1. Twenty-one out of 22 carcinomas of the exocrine 
pancreas tested positive for the presence of c-K-ras genes 
mutant at codon 12. In all seven cases analyzed, the muta- 
tion was present in both primary tumors and in their corre- 
sponding metastases. 
Discussion 
In taking advantage of the PCR in vitro gene amplification 
technique to increase the sensitivity of the RNAase A mis- 
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Figure 4. RNAase A Mismatch Cleavage Anal- 
ysis of c-K-ras DNA Sequences from Human 
Pancreatic Adenocarcinomas 
PCR-amplified DNA from 5 rrrn sections corre- 
sponding to the cases indicated at the top (see 
Table 1) were analyzed as in Figure 2 except 
that RNAase A digestion was for 60 min. The 
amounts of amplified DNA using paraffin sec- 
tions ranged from 3 to 10 PI of the total PCR 
reaction. Lanes 3 and S: 1 ul each of the PCR 
reaction, using 1 ng of purified DNA from the 
corresponding normal (N) or tumor (T) pan- 
creatic tissue of case 3 or SK-CO-1 (lane S). 
The picture corresponds to a 4 day exposure of 
the X-ray films (36 and 42 hr exposures for 
lanes 3, 13, and 16 and for lanes 14 and 15, 
respectively). The symbols are as in Figure 2. 
match cleavage method, we have shown that mutations in 
the c-K-ras gene are readily detected in amounts of tissue 
as small as that contained in a single 5 wrn paraffin section 
of tumor specimens. Therefore, our approach allows un- 
ambiguous identification of the tissue analyzed by con- 
ventional staining of adjacent sections and represents an 
improvement over the method described by Bos et al. 
(1987) because it is simpler and faster and does not in- 
volve cryostat sectioning of fresh tissue. 
The possibility of using formalin-fixed paraffin-embed- 
ded tissue specimens that can be stored at room tempera- 
ture for many years, including those obtained from autop- 
sies, greatly increases the scope of the method. Using 
PCR on formalin-fixed paraffin-embedded sections, hy- 
potheses linking the presence of specific DNA sequences 
or genomic mutations to biological phenomena can be 
rapidly tested (Shibata et al., 1988). Thus analysis of the 
frequency of mutant oncogenes in many types of tumors, 
including those of rare incidence, as well as retrospective 
correlative studies of oncogene mutational activation and 
the clinical evolution of the cancer patients (survival and 
recurrence rates), should be greatly facilitated. 
Pancreatic carcinoma is the fourth leading cause of 
death in males of cancer in the United States and.Europe. 
This reflects the aggressive nature and poor prognosis of 
the disease, with metastases present in a high proportion 
of cases at the time of diagnosis. Our findings on the inci- 
dence of mutant c-K-ras genes in pancreatic carcinomas 
imply that most, if not all, human carcinomas of the exo- 
crine pancreas contain activated c-K-ras oncogenes, and 
provide a molecular genetic diagnostic marker for this 
cancer. Of 22 total cases that we analyzed, only one was 
found to be negative in our assay. This tumor could con- 
tain a c-K-ras gene activated by a point mutation at another 
position. For instance, mutant c-K-ras genes at codon 61 
have been found in human tumors of lung (Yamamoto and 
Perucho, 1984) and colon (Bos et al., 1987) and in a pan- 
creatic carcinoma cell line (Hirai et al., 1985). We also 
have detected c-K-ras genes mutant at codon 12 in seven 
out of nine pancreatic carcinoma cell lines (unpublished 
data). 
The reason for the high incidence of mutant c-K-ras in 
cancer of the exocrine pancreas is not clear. However, it 
c-K-ras 
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is noteworthy that a mutant c-H-ras gene induces acinar 
carcinomas in the pancreas of transgenic mice when 
placed in front of the elastase I gene promoter (Quaife et 
al., 1987). This is the only reported situation where a sin- 
gle activated ras oncogene seems capable of inducing 
tumorigenesis in vivo, because neoplastic growth of the 
pancreatic cells is detectable immediately after elastase 
gene expression commences after 14 days of gestation. 
Therefore, the reproducible activation of the c-K-ras gene 
in pancreatic carcinomas (in contrast with other types of 
carcinomas) could be due to a selection phenomenon fa- 
vored by the apparent sensitivity of cells from the exocrine 
pancreas to ras activation rather than to their preferential 
exposure and/or sensitivity to specific carcinogens. 
Accurate estimation of the amount of mutant c-K-ras 
genes in these tumors is difficult because of the incom- 
plete cleavage of the single base mismatches present in 
the DNA:RNA hybrids. However, by comparing the rela- 
tive intensities of their mismatch-specific cleaved bands 
with those generated using DNA from homogenous popu- 
lations of SK-CO-l cells that contain an amplified (3- to 
4-fold) mutant c-K-ras allele (Forrester et al., 1988) and 
using our histological data to calculate the fraction of tu- 
mor cells within each tissue section (Figure 3 and data not 
shown), it is possible to assume that the mutant gene was 
present in most of the neoplastic cells from many of these 
tumors. It seems also likely that significant amounts of tu- 
mor cells from some of these specimens (cases 5, 6, and 
7, for instance) contained increased ratios of mutant 
versus normal c-K-ras alleles. A more extensive analysis 
will be required to determine whether or not there are 
correlations between the nature of the mutations and/or 
the differences in mutant c-K-ras gene dosage and ex- 
pression levels and the clinical manifestations of the cor- 
responding tumors. 
The ubiquitous presence of the mutant c-K-ras gene in 
most of these tumors (in different tumor regions, in the 
majority of the tumor cells, and in both primary tumors and 
their corresponding metastases), either from autopsies or 
from surgical resections, suggests that c-K-ras mutational 
activation is an early event in cancer of the exocrine pan- 
creas. These results, especially the persistence of the ac- 
tivated oncogene in the metastases, also support the con- 
cept that mutant ras genes are actively involved in the 
maintenance of the tumor phenotype and continuosly 
contribute to the process of tumor progression, including 
the metastatic process. In conclusion, our studies suggest 
that the reproducible and therefore predictable somatic 
mutational activation of the c-K-ras gene in pancreatic car- 
cinoma plays a direct and critical role in the genesis of this 
common type of human cancer. 
Experimental Procedures 
Cell Lines and Tumors 
The origins of the human normal foreskin fibroblasts (HNF) and the SK- 
CO-1 colon carcinoma cell line (Fogh and Trempe, 1975) and their cul- 
ture conditions have been previously described (Perucho et al., 1981; 
Winter et al., 1985). Frozen specimens of nonfixed pancreatic tumors 
were obtained from the Tissue Cooperative Human Network of the 
University of Alabama at Birmingham (cases 1 and 3) and from the 
University Hospital at Stony Brook (cases 2 and 4). The paraffin- 
embedded tissues from 1971 to 1987 were obtained from the files of 
the LAC-USC Medical Center (pancreatic carcinomas 5 through 17 
and gall bladder carcinomas) or the Winthrop University Hospital at 
Mineola, Long Island, NY. (pancreatic carcinomas 18-22). Surgical 
resections and biopsies were fixed in 10% buffered formalin immedi- 
ately upon removal. Autopsies were performed within 30 hr after death. 
All tissues were routinely paraffin embedded. The pancreatic tumors 
were all ductal adenocarcinomas. The gall bladder tumors were all 
adenocarcinomas. 
Plasmids and Oligonucleotide Primers 
RNA probes were generated using pAKINgly (Winter et al., 1985) a 
pSP65 (Promega) derivative containing normal sequences from the 
first coding exon of the c-K-ras gene from the Sau3A sate at position 
+97 to the Pstl site at approximately 180 in the first intron, relative to 
the ATG initiation codon (Nakano et al., 1984; McGrath et al., 1983). 
For in vitro transcriptions, pAKINgly was linearized with Aatl, located 
at the splicing junction, 10 bp upstream of the ATG codon (Figure 1). 
The primers used for PCR amplification of c-K-ras sequences were 
SCATGTTCTAATATAGTCACA?(A) and 3’GTTATCTCCATTTAGAACAA 
5’(B). Primer A hybridizes to the noncoding DNA strand from positions 
-53 to -23 and primer B hybridizes to the coding strand from posr- 
tions +104 to +123 (Nakano et al., 1984, McGrath et al.. 1983). The 
antisense RNA probes generated by linearizing the plasmid with Aatl 
span from +97 to -10 and are therefore included in the amplified re- 
gion (see Figure 1). 
In Vitro Transcriptions 
Uniformly labeled RNA probes were synthesized with the SP6 poly- 
merase in vitro transcription system (Melton et al., 1984) using 50 uCi 
of c#aP]CTP (Amersham, 10 uCi/ml, 400 Cilmmol) as described 
(Winter et al., 1985) in the presence of 30 KM of unlabeled CTP Synthe- 
sized RNA probes were resuspended in 30 ul of loading buffer (97% 
formamide; 0.1% SDS; 10 mM Tris-HCI [pH 7.0); 0.01% bromophenol 
blue and xylene cyanol) and electrophoresed in 1.5 mm thick denatur- 
ing urea-polyacrylamide gels (Maniatis et al., 1982). The gels were ex- 
posed to XAR-5 Kodak film for 30 set, the radioactive bands were ex- 
cised from the gel, and the RNA probes were eluted by incubation for 
3 hr at 37°C with gentle shaking in 375 ul of 2 M ammonium acetate, 
0.1% SDS. The eluted probes were precipitated with ethanol after add- 
ing 30 ug of yeast tRNA, dried, dissolved in 50 ul of hybridization buffer 
(85% formamide, 0.4 M NaCI, 1 mM EDTA, 40 mM PIPES [pH 6.71) and 
stored at -7OV. 
Hybridizations and RNAase A Digestions 
DNA:RNA hybridizations were performed in 30 ul of hybridization 
buffer for 12-16 hr at 40945°C. Purified probes (25 x 10s cpm) were 
hybridized to PCR amplified DNA in the presence of 20 ug of yeast 
tRNA, after heating at 90°C for 10 min. RNAase A digestions were per- 
formed at 30% by adding to the samples 300 ul of a buffer containing 
20 uglml of RNAase A (type Ill A, Sigma), 10 mM Tris-HCI (pH 7.5); 1 
mM EDTA; 0.2 M NaCI, and 0.1 M LiCl (Myers et al., 1985). The reac- 
tions were terminated by adding 10 ul of 20% SDS and 5 ul of Pro- 
teinase K (10 mglml, Beckman) and incubated for 15 min at 37%. The 
samples were extracted with phenol:chlorophorm:isoamyl alcohol af- 
ter adding yeast tRNA (10 ug), ethanol precipitated, and analyzed in 
0.5 mm thick urea-polyacrylamide gels for 2 hr at 250 volts. 
PCR-Mediated Amplification of c-K-ras Sequences 
from Paraffin Sections 
We used the preparation method of Shibata et al. (1988). A single 5-10 
urn section cut from the block was placed in a 500 fri microtube. Subse- 
quent sections were stained with hematoxylin and eosin to confirm the 
exact tissue analyzed. The average surface area of the tissue was 1.0 
cm*, although smaller fragments were used successfully. The sec- 
tions were deparaffinized by adding 400 ttt of xylene, and then cen- 
trifuged for 5 min. The xylene was decanted and its residue removed 
with 400 ul of 95% ethanol. The tissue pellets were dessicated and 100 
ul of the PCR mix was added directly to the tubes. The PCR mix con- 
tained 10 mM Tris (pH 7.5) 50 mM NaCI, 10 mM MgCla, 1.5 mM Of 
each dNTP and 1 umol of each primer (Saiki et al., 1985). The tubes 
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were heated at 100°C for 10 min and then subjected to 40 cycles of am- 
pllftcation on a modified liquid handling apparatus (ProlPette, Cetus 
Corporation, Emeryville, CA) which sequentially denatured, cooled, 
and added DNA Polymerase I (Klenow. US Biochemicals, Cleveland, 
OH) to the samples. 
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